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approaches to model the relationship 
between molecular structure and bioac-
tivity. Although we and others heralded the 
promise of “materiomics,” which refers to 
similar approaches for biomaterials,[1–4] the 
field is only slowly adopting these tools. 
This lag is partly explained by the high level 
of design complexity that biomaterial engi-
neers face. Whereas most pharmaceutically 
active compounds act on single molecules 
(typically proteins), successful biomaterials 
also act at the cellular and tissue level. For 
example, a vascular stent opens the occluded 
blood vessel and facilitates endothelial and 
vascular smooth muscle cell adhesion, and 
titanium hip implants bond to bone at the 
cellular level while providing mechanical 
support to the bone as a whole. Materials 
ultimately interact at the molecular, cellular 
and tissue levels, and their effective design 
must consider this hierarchy.[5–10]
The use of animal models has been 
effective to study biomaterials at the tissue 
level, but understanding at the molecular 
and cellular levels has been impeded by 
the complexity of multiscale material prop-
erties that combine and converge to influence cell behavior.[11] 
For example, surface energy and wetting properties can affect 
protein binding and the subsequent adhesion of cells,[12] while 
surface topography and elasticity both affect mechanobi-
ology.[13,14] While osteoblasts are essential for bone formation, 
macrophages and osteoclasts have also been suggested to play 
an important role.[15] Despite a number of high-quality studies 
that aim to improve our understanding of how material proper-
ties influence cell behavior, the relationship between the two is 
still a black box.[16–20]
In this study, we introduce a holistic approach toward 
understanding cell–biomaterial interactions by generating a 
transcriptional landscape of osteogenic cells coupled to param-
eters known to influence bone formation in vivo. We leveraged 
existing knowledge on calcium phosphate ceramics, which are 
widely applied as synthetic bone-graft substitutes, and have tun-
able parameters (e.g., crystallinity, porosity, chemical composi-
tion) that elicit profoundly different biological responses.[21] For 
instance, surface microstructure correlates to the induction of 
ectopic bone tissue in vivo.[22–24] Furthermore, calcium ions can 
induce the expression of the bone growth factor BMP2,[25–27] 
New engineering possibilities allow biomaterials to serve as active orchestra-
tors of the molecular and cellular events of tissue regeneration. Here, the 
molecular control of tissue regeneration for calcium phosphate (CaP)-based 
materials is established by defining the parameters critical for tissue induc-
tion and those are linked to the molecular circuitry controlling cell physiology. 
The material properties (microporosity, ion composition, protein adsorption) 
of a set of synthesized osteoinductive and noninductive CaP ceramics are 
parameterized and these properties are correlated to a transcriptomics profile 
of osteogenic cells grown on the materials in vitro. Using these data, a genetic 
network controlling biomaterial-induced bone formation is built. By isolating 
the complex material properties into single-parameter test conditions, it is ver-
ified that a subset of these genes is indeed controlled by surface topography 
and ions released from the ceramics, respectively. The gene network points to 
a decisive role for extracellular matrix deposition in osteoinduction by genes 
such as tenascin C and hyaluronic acid synthase 2, which are controlled by 
calcium and phosphate ions as well as surface topography. This work provides 
insight into the biomaterial composition and material engineering aspects 
of bone void filling and can be used as a strategy to explore the interface 
between biomaterials and tissue regeneration.
1. Introduction
The field of pharmacology has seen tremendous advances in the 
past decades after its adoption of high-throughput screening, the 
large-scale use of transcriptomics to decipher the biological com-
plexity of diseases and their treatments, along with computational 
Adv. Mater. 2017, 29, 1603259
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and surface topography induced osteogenic differentiation,[28] 
but it is unknown if these parameters contribute to bone for-
mation in vivo. In addition, the molecular mechanisms driving 
bone formation remain unclear, as are the material parameters 
that are causally linked to it. In this study, we define the mate-
rial-induced transcriptional landscape in osteoblasts in vitro and 
show a correlation between in vivo bone formation and induc-
tion of a specific gene set by defined biomaterial parameters.
2. Results
2.1. Calcium Phosphate Synthesis Parameters Correlate  
to In Vivo Osteogenic Potential
In order to determine how material parameters correlate to 
their osteogenic potential, we produced a series of materials 
with three different chemical compositions: hydroxyapa-
tite (HA); β-tricalcium phosphate (TCP); and a mixture of 
80 ± 5% HA and 20 ± 5% β-TCP, referred to as biphasic cal-
cium phosphate (BCP). Next, we varied the microstructural 
properties while preserving the chemical composition and 
macroporosity (Figure 1) by sintering the ceramics at dif-
ferent temperatures.
For both HA and BCP, we synthesized a material with rela-
tively small grain size, high microporosity, and high specific 
surface area (named HAi and BCPi from here on) as compared 
to their counterparts (named HAn and BCPn from here on, 
Figure S1, Supporting Information) (the “i” and “n” stand for 
the osteoinductive and non-osteoinductive properties of these 
materials, respectively, as shown in the in vivo study at the end 
of this section). TCP particles (only one type) were prepared 
with structural properties similar to HAi and BCPi (Figure 1 and 
Figure S1, Supporting Information). To parameterize material 
Adv. Mater. 2017, 29, 1603259
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Figure 1. Macro- and microstructure of calcium phosphate ceramics. A) The macrostructure of the different ceramics sintered at varying temperatures 
is similar, as shown by SEM images of the polished ceramic bodies used to prepare the ceramic particles. A separation between non-osteoinductive 
(non OI; top row) and osteoinductive (OI; bottom row) ceramics is made, referring to the results of the in vivo osteoinductivity study (Figure S4, 
Supporting Information). B) In contrast, the microstructure of the non-osteoinductive ceramics (top row) is different from that of the osteoinductive 
ceramics (bottom row), as depicted by the SEM images. HA, hydroxyapatite; BCP, biphasic calcium phosphate; TCP, tricalcium phosphate particles, 
“i”, osteoinductive; “n”, non-osteoinductive (macrostructure scale bar is 1000 µm; microstructure scale bar is 20 µm).
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properties, we measured porosity (Figure S1, 
Supporting Information), chemical composi-
tion, protein adsorption and calcium release, 
confirming that the material pairs differing 
in microstructure (BCPn–BCPi and HAn–
HAi, respectively) had the same chemistry 
(Figure S2, Supporting Information). Protein 
adsorption was quantified after immersion 
in medium containing fetal bovine serum. 
Interestingly, the materials with unstruc-
tured surfaces (HAn and BCPn) adsorbed 
more protein relative to surface area than 
their microstructured equivalents and TCP 
(Figure S3, Supporting Information). In an 
earlier study by Wang et al.[29] comparing two 
different HA ceramics, a somewhat lower 
adsorption of rat serum was observed than in 
our study. In another study by Wang et al.,[30] 
comparing HA, BCP, and TCP ceramics, the 
total amount of proteins adsorbed on the 
ceramics were significantly lower than in 
our study. However, comparable to our find-
ings, the ceramics with a lower specific sur-
face area showed the highest adsorption of 
human serum protein. In contrast, in a study 
by Li et al.,[31] an opposite trend was observed 
for two BCP ceramics. It should be noted 
that these comparisons among different studies should be criti-
cally reviewed because of differences in experimental setup and 
the way data are presented. Nevertheless, they all suggest that 
both the structural and the chemical properties play a role in 
protein adsorption.
Calcium release over a period of two weeks was highest 
from TCP (Figure S3, Supporting Information). Although 
both BCP materials had a similar calcium release, the release 
from HAi was comparatively higher, and the release from HAn 
was the lowest among all materials. It should be noted that 
the medium used for the release study, the simulated physi-
ological solution, represents the pH and the ionic strength of 
a physiological environment, but not the level of saturation 
with calcium and inorganic phosphate ions. In vivo, where 
body fluids contain approximately 2 × 10−3 M and 1 × 10−3 M 
calcium and phosphate, respectively, none of these ceramics 
is expected to be soluble. This was also supported by our ear-
lier studies in which the concentrations of calcium and phos-
phate were measured upon immersion of the ceramics in 
alpha-MEM or cell culture medium.[32–34] In these studies, a 
decrease of calcium and inorganic phosphate concentrations 
was observed. Nevertheless, in our previous study in vivo 
we observed extensive degradation of TCP.[35] Indeed, within 
12 weeks of implantation in bone, more than 50% of the 
implanted material was degraded, showing that also in vivo, 
calcium and phosphate release occurs.
Here, in order to assess their biological activity, we implanted 
the materials intramuscularly in dogs and examined ectopic 
bone formation after 12 weeks by histomorphometry. We 
observed a correlation between the structure of the materials 
and bone formation. In chemically paired compositions, the 
microstructured version of the materials induced ectopic bone 
formation whereas no bone was induced by the unstructured 
materials (Figure 2 and Figure S4, Supporting Information).
In summary, we produced and defined the microstructural 
characteristics and bioactivity for five ceramic materials. In the 
next sections, we studied the cellular and molecular mecha-
nisms of the material–cell interactions for these ceramic mate-
rials using transcriptomics. We focused in particular on the 
influence of structural and chemical material parameters.
2.2. Pathway Analysis and Genetic Network  
Creation for Osteoinductivity
Before zooming in on the role of specific material characteristics 
on the transcriptome of the cell, we first performed a more gen-
eral analysis of transcriptomic differences, focusing on pathway 
and network analysis. To describe the genetic interactions related 
to in vivo osteoinductivity, we analyzed the transcriptomic 
response of the human MG-63 osteogenic cell line cultured on 
chemically identical material pairs (HAi vs HAn; BCPi vs BCPn) 
(Figure 3). The HA-based and BCP-based material comparisons 
respectively revealed 168 and 3247 genes to be differentially 
expressed. Eighty-eight genes overlapped between these two lists 
and these were used for further analysis (Table S1, Supporting 
Information). We performed a pathway over-representation 
analysis using the ConsensusPathDB tool (CPDB) to see if our 
overlap gene list is involved in any established signaling path-
ways. Three significantly overrepresented signal transduction 
pathways involving 10 significant genes were found: i) phar-
macodynamics of vemurafenib, ii) HIF-1-alpha signaling, and 
iii) integrin cell surface interactions (Table 1). The top pathway 
describes the effect of vemurafenib, which is at first sight a 
Adv. Mater. 2017, 29, 1603259
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Figure 2. Induction of ectopic bone formation by microporous calcium phosphate ceramics. 
Osteoinductive potential of calcium phosphate ceramics implanted intramuscularly in dogs, 12 
weeks after implantation. Representative histological sections are shown of (A) an osteoinduc-
tive calcium phosphate ceramic (TCP, left) and (B) a non-osteoinductive one (BCPn, right). 
Histological sections of all materials can be found in the Figure S4 in the Supporting Informa-
tion. Basic Fuchsin stains the newly formed bone red, methylene blue stains fibrous tissue blue, 
and the scaffold is shown in black (scale bar is 250 µm). Osteocytes can be seen embedded 
in the bone matrix, and bone marrow can be seen in the top left corner of the TCP sample. In 
contrast, only fibrous tissue can be observed in the non-inductive ceramics.
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confusing hit because vemurafenib is a compound used to treat 
metastatic melanoma. However, it is also known to have the side-
effect of inhibiting osteogenesis, which explains why it shows up 
in this analysis.[36] This is not surprising because the genes that 
are affected in this vemurafenib-induced pathway (i.e., MAPK3, 
PDGFRA and ETS1) are all known to be key players in osteo-
genesis.[37,38] The HIF-1-alpha transcription factor pathway is 
hypoxia-responsive and plays a crucial role in developing bone by 
coordinating new blood vessel formation,[39] while integrin sign-
aling has been shown to influence osteogenesis and osteoblast 
differentiation.[40] Indeed, our osteoinductivity overlap gene list 
is involved in highly relevant established signaling pathways.
We next used our overlap gene list to create a gene network 
in CPDB in order to visualize the interactions between the 
88 osteoinduction genes and their co-regulated genes, ena-
bling us to uncover relationships between corresponding pro-
teins, intermediate signaling proteins, and crucial transcrip-
tion factors. Since such networks are based on continuously 
updated databases, new connections can be discovered, not yet 
recorded in established pathways. Using the network analysis 
tool CytoScape, additional transcription factors and targets, 
derived from the ENCODE transcription factor database, were 
added to the network (Figure S5A, Supporting Information). 
Hub genes that play a central role in this osteoinductivity 
network were subsequently identified by determining the 
number of connections from each protein (Figure S5B, Sup-
porting Information). Five genes with a very high connected-
ness were identified (ATF3, BATF, ETS1, JUND, MAFF), all 
transcription factors affecting up to several hundred target 
Adv. Mater. 2017, 29, 1603259
www.advancedsciencenews.comwww.advmat.de
Figure 3. Gene selection and analysis procedure. Genes differentially expressed in MG-63 cells cultured on non-osteoinductive and osteoinductive 
materials (HA and BCP) were determined as described in the Methods section, and 88 genes overlapped between osteoinductive HA and BCP. The 
top 500 differentially expressed genes between non- and osteoinductive ceramic materials were compared in MG-63 (two independent microarray 
datasets), iMSCs, and hMSCs, then checked for overlap with our list of 88 genes. This comparison resulted in 11 cross-study overlapping genes.
Table 1. Significantly over-represented pathways found in CPDB.
Pathway Source Significant gene membersa) q-valueb)
Vemurafenib Pathway, 
Pharmacodynamics
PharmGKB MAPK3; PDGFRA; ETS1 0.0208
HIF-1-alpha transcription 
factor network
PID HK2; CXCL12; ETS1; EGLN1 0.0208
Integrin cell surface 
interactions
Reactome CD47; COL13A1; ITGB5; TNC 0.0208
a)As found in the list of 88 genes; b)The q-value represents the over-representation 
analysis p-value corrected for false discoveries.
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genes. ATF3, ETS1, and MAFF were also present in our list of 
88 overlapping genes.
To condense the network to a visually more manageable size, 
we performed a second network analysis in CytoScape using 
the considerably smaller Transcription Factor Encyclopedia 
(TFe) database, which draws information solely from manu-
ally curated literature. Figure 4 shows high connectedness and 
a long signaling cascade with 14 additional TFe transcription 
factors and 1 target gene (VIP). Interestingly, 9 out of 10 of the 
differentially expressed genes that were found in the significant 
pathways in Table 1 were also found in this network. The net-
work represented in Figure 4 provides a map of the molecular 
mechanisms regulating osteoinduction. Interestingly, a dense 
cloud of correlated genes is seen around the hypoxia inducible 
factors 1 and 2 (HIF1A, EPAS1, ARNT), suggesting a role for 
hypoxia signaling in osteoinduction.
2.3. Four Genes As Basis for a Molecular  
Model of Osteoinduction
For the next step in our transcriptomics approach, we wanted 
to select a small set of genes to investigate in greater detail 
with respect to their relationship to specific material proper-
ties. Genes correlating to material-induced bone in vivo should 
ideally also be regulated in other osteogenic cell lines and by 
other known osteoinductive materials. Therefore, we exam-
ined the overlap between our data set and three previously 
published transcriptomics datasets in which three cell types 
(immortalized and primary bone marrow mesenchymal stem 
cells, and MG-63 cells) were cultured on osteoinductive versus 
non-inductive ceramic materials (TCP and HA).[32,41] Doing 
so enabled us to filter down to a smaller set of robust genes 
involved in osteoinductivity. Twelve genes (Figure 3, Table 2) 
overlapped between these data sets, of which seven are identi-
fied in our network, and six of which are in the main signaling 
cascade (Figure 4). To validate these seven genes indepen-
dently, we performed an RT-PCR experiment in MG-63 cells 
on the osteoinductive versus non-inductive ceramics (HAn 
vs HAi; BCPn vs BCPi) (Figure 5 and Figure S6, Supporting 
Adv. Mater. 2017, 29, 1603259
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Figure 4. Network constructed through an initial network formation in CPDB followed by CyTargetLinker analysis in CytoScape using the TFe database. 
Original osteoinductivity-related input genes (48 connected + 40 unconnected), genes added by CPDB (33), and genes added by CyTargetLinker (14) 
are represented by filled red, blue, and green nodes, respectively. Transcription factors are indicated with rounded squares and non-transcription factors 
by circles (CPDB) or hexagons (CyTargetLinker). The positions of the 11 cross-study genes are indicated with gray boxes.
Table 2. List of 11 cross-study overlap genes with their full name.
Official Symbol Name
ATF3 Activating transcription factor 3
CEBPD CCAAT/enhancer binding protein (C/EBP), delta
CEMIP Cell migration inducing protein, hyaluronan binding
EGLN1 Egl-9 family hypoxia-inducible factor 1
ELL2 Elongation factor, RNA polymerase II, 2
HAS2 Hyaluronan synthase 2
MKNK2 MAP kinase interacting serine/threonine kinase 2
PPP1R3B Protein phosphatase 1, regulatory subunit 3B
TNC Tenascin C
TNFRSF21 Tumor necrosis factor receptor superfamily, member 21
TPM1 Tropomyosin 1 (alpha)
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Information). HAS2, CEMIP, ATF3, TNFRSF21 and TNC 
were found to be differentially expressed. In addition, all but 
TNFRSF21 were expressed higher on osteoinductive TCP 
ceramics than on the non-inductive HAn and BCPn. Interest-
ingly, these four core genes (HAS2, CEMIP, ATF3, and TNC) 
all have a well-described role in the osteogenic process but 
have not as of yet been associated with biomaterial-induced 
bone formation. We also assessed the expression of BMP2 
(not a core gene), which responds to calcium and phosphate 
ions.[42] BMP2 was significantly upregulated on the TCP par-
ticles compared to the unstructured HAn, BCPn, and polysty-
rene, but not between HAi and HAn (Figure S6, Supporting 
Information).
Having selected a list of robust core genes, in the next sec-
tion we examined their role with respect to specific material 
properties. For this we used an approach where we deconvo-
luted material properties and linked this to gene expression 
levels based on RT-PCR.
2.4. Deconvolution of Material Properties
Ceramic materials are complex systems with highly inter-
twined material properties and concomitant biological 
effects. To further unravel the material property that caused 
the observed gene expression differences, we attempted to 
simplify the ceramic system by deconvoluting the mate-
rial properties. We chose microstructure and ion release as 
two material properties involved in the osteogenic process 
based on our previous studies.[25,32,41] We engineered two 
experimental settings in which we could avoid confounding 
effects of other material parameters. To investigate the effect 
of topography on the expression of the four core genes, we pro-
duced a series of micro-roughened surfaces in polystyrene. To 
this end, we replicated the surfaces of two TCP-based ceramic 
discs with two different temperatures (1150 °C and 1050 °C 
for TCPa and TCPb, respectively) into polystyrene (termed 
PSa and PSb). We chose these disc-based ceramics because 
it is not possible to reproduce microstructures of particles, 
and because these discs induce bone formation in vivo with 
a clear relation between osteoinduction and micrometer-scale 
roughness (Figure S7, Supporting Information). Quantifica-
tion of the grains on the imprinted surfaces revealed similar 
dimensions as the original ceramics (Figure 6). After con-
firming that the microstructured polystyrene surfaces allow 
cell adhesion and growth, gene expression of the four core 
genes was assessed after 7 days of MG-63 culture. The expres-
sion of TNC, HAS2, CEMIP, and ATF3 was inversely related 
Adv. Mater. 2017, 29, 1603259
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Figure 5. Gene expression validation. Relative mRNA levels (fold change) of the four core genes on non- and osteoinductive HA and BCP, as well as 
on osteoinductive TCP, versus tissue culture polystyrene (PS). The expression of HAS2, CEMIP, TNC, and ATF3 was altered after 48 h of culture on 
the different ceramics (triplicate experiment). ANOVA with Bonferroni correction was used to test the statistical significance of the expression between 
the non- and osteoinductive ceramics (*p < 0.05, **p < 0.01). ANOVA with Dunnett correction was used to test the statistical significance (#p < 0.05, 
##p < 0.01) of the differential expression between MG-63 cultured on the materials and PS.
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to grain size: mRNA levels for all four genes were greatest on 
the replicated surface of TCPb (PSb, Figure 7). TNC showed a 
significant, 4.5-fold upregulation on PSb compared to the flat 
surface. BMP2 expression did not respond consistently to the 
surface of the imprints.
While topographical cues play a key role in cellular responses 
to ceramics and biomaterials in general, the presence of calcium 
and inorganic phosphate ions have also been shown to greatly 
affect cell behavior.[25,32] We therefore asked whether expression of 
the four core genes associated with osteoinductivity is influenced 
by these two ions. MG-63 cells were cultured in medium con-
taining elevated levels of calcium (7.8 × 10−3 M) and phosphate 
(10 × 10−3 M) relative to basic medium (1.8 × 10−3 M calcium 
and 1 × 10−3 M phosphate, respectively). During these experi-
ments no precipitation of calcium phosphate was observed. 
Of the four core genes, only CEMIP and TNC responded sig-
nificantly to the ions (Figure 8). The expression of CEMIP 
significantly decreased in the presence of elevated calcium and 
phosphate levels in the culture medium. These two ions sepa-
rately downregulated the expression by approximately 7-fold, 
whereas the combination of the two induced a 30-fold decrease 
after two days in culture. The effect on TNC was milder, with a 
2- to 3-fold upregulation in the varying conditions, similar to the 
effect size observed on the different ceramics. Furthermore, a 
significant upregulation of BMP2 (not a core gene) was observed 
when MG-63 cells were exposed to the combined high calcium 
and phosphate concentrations. In conclusion, CEMIP and TNC 
were significantly affected by the presence of calcium and/or 
inorganic phosphate ions.
2.5. A Potential Role for Hyaluronic Acid in Osteoinductivity
Of the four core genes, HAS2 and CEMIP are both involved in 
hyaluronic acid synthesis, indicating a role for hyaluronic acid 
in ceramic-induced osteogenesis. To check whether differential 
expression of the genes correlated to different levels of hyalu-
ronic acid, we quantified its presence in the extracellular matrix 
of MG-63 cells grown on ceramic particles. Indeed, hyaluronic 
acid was consistently produced more by cells on osteoinductive 
ceramics than non-inductive ceramics (Figure 9A). Moreover, 
we detected more of the biologically active high-molecular-
weight chains (Figure 9B).
3. Discussion
What triggers osteogenic cells to form bone tissue in vivo? 
More specifically, which signals from biomaterials initiate this 
response and how do cells transmit them to execute the osteo-
genic program? This knowledge is essential to both rationally 
design and implement screening strategies to engineer bioac-
tive materials.[8] To this end, we present the transcriptional 
landscape of biomaterial-induced bone formation in vivo and 
uncover a role for hyaluronic acid synthesis in the initial steps 
of osteoinduction. Furthermore, we identified biomaterial 
parameters that regulate gene expression, and provide a tran-
scription factor network potentially involved in the regulation 
of material-induced bone formation. This report unravels part 
of the molecular mechanism behind ceramic-induced bone 
Adv. Mater. 2017, 29, 1603259
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Figure 6. Replication of ceramic surfaces in polystyrene. A) The left column of images represents the surfaces of three TCP discs sintered at varying 
temperatures (1150 and 1050 °C; TCPa and TCPb, respectively) and a flat cyclic olyfinic polymer surface used as intermediate in the replication process. 
The right column of images depicts the surfaces in polystyrene (PS) replicated using micropatterning tools (scale bar is 5 µm). B) The grain sizes 
were measured on both the original ceramic surfaces and the imprinted PS surfaces to confirm replication of the surface structure. Average grain size 
was determined from 60 different grains from three independent SEM images using Image J. There are no significant differences between ceramics 
and PS imprints.
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formation, which also represents a paradigm for analysis of 
tissue formation at the biomaterial interface in which both the 
complexity of biology and materials are parameterized and cor-
related (Figure 10).
Reverse engineering of osteoinduction in vivo has to deal 
with three levels of complexity: cells (cellular mechanisms), 
materials (topography and chemical interactions at the mate-
rial surface), and tissues (multicellular environment including 
the extracellular matrix). In this study, we approach cellular 
complexity by using transcriptomics, in which the expression 
of all genes is assessed in vitro and correlated to bone forma-
tion in vivo. Analysis of our data revealed the involvement of 
previously identified osteogenic mechanisms such as integrin 
signaling[43] and the MAPK, ERK, AP-1 pathway.[44] We also 
found that the transcription factor HIF1α potentially acts as a 
hub protein regulating the expression of a significant number 
of genes in our network, analogous to its role in in vivo bone 
formation.[45] Studies investigating whether a causal link exists 
between hypoxia signaling and osteoinduction are in progress. 
Although the BMP signaling cascade did not emerge from 
our analysis, the role of hyaluronic acid synthesis and the con-
firmed induction of BMP2 on inductive ceramics does point to 
a role for BMP2. We hypothesize that osteoinductive ceramics 
trigger the osteoprogenitor to secrete an extracellular matrix 
rich in hyaluronic acid. Its known potentiating effect on the 
biological activity of BMP could thus provide part of the oste-
oinductive signal.[46] We are currently investigating whether a 
calcium/phosphate–hyaluronic acid–BMP2 axis plays a role in 
osteoinductivity. Hyaluronic acid is also known to interact with 
other growth factors, such as BMP7 and VEGF.[47,48] Whether 
this also plays a role in the calcium–phosphate–hyaluronic acid 
axis remains to be investigated.
In the studies reported here, focused parameters of mate-
rial complexity were analyzed for their effect on specific gene 
expression. Although we were able to demonstrate that our 
four core genes responded to some combination of surface 
topography, calcium, and phosphate ions, how these three 
variables affect the expression of individual genes in our net-
work remains to be determined. Moreover, we need to examine 
additional parameters, such as protein binding, of inductive 
ceramics. We observed that osteoinductive ceramics have a high 
amount of protein per volume of ceramic, but relatively low 
binding relative to the surface area. Additionally, future studies 
are needed to validate our gene network using other osteoin-
ductive materials. For instance, we observed that 3D ceramic 
particles outperform their chemically identical discs in terms of 
bone induction in vivo, implicating a role for the macro porous 
architecture in the osteoinductive process,[49] for instance by 
tuning cell–cell interaction. Alternatively, the pores provide a 
chemically isolated niche in which both ions released from the 
materials and the molecules secreted by the osteogenic cells 
reach a critical level to boost osteogenesis. We therefore advo-
cate the establishment of libraries of benchmark materials, in 
which material parameters are independently designed and 
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Figure 7. Gene expression on polystyrene mimicking ceramic surfaces. Relative mRNA levels (fold change) of HAS2, CEMIP, TNC, ATF3 (core genes) 
and BMP2 in MG-63 cells cultured on PSa and PSb (replicated from TCPa and TCPb respectively) versus flat PS (triplicate experiment) for 7 days. 
ANOVA with post-hoc Tukey was used to test statistical significance (*p < 0.05). Besides the indicated significance between PSb and flat for TNC, no 
statistical significance was reached in any of the other comparisons between flat, PSa, and PSb.
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Figure 8. Gene expression under the influence of calcium or phosphate ions. MG-63 cells were cultured on polystyrene in the absence of ceramics in 
the presence of the respective ions (concentrations indicated in mM; triplicate experiment) for 48 hours. Relative mRNA levels (fold change) of HAS2, 
CEMIP, TNC, ATF3 (core genes), and BMP2 versus basic medium (1.8 × 10−3 M Ca and 1 × 10−3 M phosphate; white bars) are shown. ANOVA was 
used to test statistical significance and only fold changes exceeding 2.5 were reported significant (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure 9. Hyaluronic acid production by MG-63 cultured on ceramics. A) Hyaluronic acid was extracted from the extracellular matrix (ECM) of MG-63 
cultured on ceramics or flat polystyrene (PS) and quantified by ELISA in duplicate. ANOVA with Bonferroni correction was used to test the statistical 
significance between ceramics (**p < 0.01, ***p < 0.001) or between ceramics and PS (#p < 0.05, ###p < 0.001). B) Hyaluronic acid molecular-weight 
distribution by gel electrophoresis. The first gel lane contains a low-molecular-weight hyaluronic acid reference (15–30 kDa), whereas the higher-
molecular-weight hyaluronic acid is mostly found in the ECM of MG-63 cells grown on osteoinductive CaP ceramic samples (HAi, BCPi, TCP), where 
it is present as a smear in the upper part of the lanes. The bands at the bottom consist of other low-molecular-weight glycosaminoglycans.
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their effects on the osteogenic transcriptional landscape inde-
pendently determined.
The final level of complexity of osteoinduction is the tissue. 
We chose to investigate the osteoblast cell line MG-63 because 
it is known to respond to many known osteogenic signals such 
as BMP2,[50] PTH, and vitamin D3.[51] Furthermore, we previ-
ously observed that inductive ceramics can induce ectopic bone 
formation by mesenchymal stem cells, which points at a bone-
inducing effect at the level of the osteoprogenitor cell.[35] How-
ever, material-induced bone formation is a process that takes 
several weeks, during which the materials are sequentially inter-
acting with a multitude of cell types ranging from pericytes to 
neutrophils, osteoclasts,[52] macrophages, and endothelial cells. 
Indeed, a role for macrophages in osteoinduction has been pro-
posed[53] and it would be interesting to see how macrophage-
derived signals feed into the molecular circuitry described in 
this paper. Eventually, the complexity of 
material-induced bone formation should be 
studied in vivo, for instance in the osteo-
inductive mouse model we recently discov-
ered.[54] State of the art technologies such as 
tomo-sequencing[55] or in situ sequencing[56] 
may provide the spatiotemporal resolution 
needed to investigate the molecular events 
leading to bone formation.
4. Conclusions
We presented a transcriptional landscape of 
material-induced bone formation and were 
able to correlate expression of individual 
genes in this network to defined material 
parameters. The potential role of hyaluronic 
acid deposition by osteoprogenitors in the 
osteoinductive process is a starting point for 
unraveling the molecular mechanism and a 
biological readout for material engineering.
5. Experimental Section
5.1. Synthesis of Calcium Phosphate 
Ceramics
The materials in this study were used in three 
forms: macroporous particles (as used in Figure 1, 
3, 5, and 9, and Figure S1–S3 and S6, Supporting 
Information), discs without macropores (“dense 
discs,” as used in Figure 6), or cylinders with cut 
gaps (“dense cylinders,” as used in Figure 2 and 
Figure S4 and S7, Supporting Information). For 
all forms, five different porous calcium phosphate 
ceramic bodies were prepared from apatite powders 
with Ca/P ratio of 1.67 (HA), 1.64 (BCP), or 
1.50 (TCP). Briefly the apatite powders were either 
purchased (for HA, product number 1.02196.9025, 
Merck Millipore) or wet synthesized (for BCP and 
TCP) with calcium- and phosphate-containing 
solutions (calcium hydroxide, purum p.a., Fluka 
(product number C991T92) and phosphoric acid 
≥85%, puriss. p.a. Ph.Eur, Sigma–Aldrich: Fluka (product number 79620), 
respectively), then green bodies were made with diluted H2O2 solution 
(1–2%) and wax particles at 60 °C. The green bodies were obtained 
after sintering at high temperatures for 8 h. The sintering temperatures 
were as follows: 1150 °C for HAi, 1250 °C for HAn, 1150 °C for BCPi, 
1300 °C for BCPn, and 1050 °C for TCP. The particles (1–2 mm) were 
crushed, sieved, and ultrasonically cleaned with acetone, 70% ethanol 
and demineralized water, dried at 80 °C, and sterilized in an autoclave at 
121 °C for 30 minutes. All chemicals were AR grade.
Next, dense green ceramic bodies were prepared from synthesized 
apatite powder with a Ca/P ratio of 1.50 using diluted H2O2 solution 
(0.1%) at ambient temperature and sintered at 1150 °C (TCPa) or 
1050 °C (TCPb, similar to macroporous TCP particles described above). 
Dense ceramic discs (Ø 9 mm × 1 mm) and cylinders (Ø 9 mm × 10 mm) 
with two cut gaps (0.8 mm in width) were machined from the ceramic 
bodies using a lathe and a diamond-coated saw microtome, and 
were ultrasonically cleaned, and heat sterilized at 160 °C for 2 h. 
The gaps were created in order to allow for bone growth into the 
cylinder gap.
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Figure 10. Integration of biology and material science toward a computational approach for 
new biomaterial development. Both bone (left) and bone-graft substitutes (right) can be decon-
structed into their elementary components, i.e., gene expression and single material parame-
ters, respectively. The interplay between them can be studied using computational approaches.
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5.2. Material Characterization of the Calcium  
Phosphate Ceramics
The chemical properties and crystal structures of CaP ceramics 
were analyzed using Fourier transform infrared (FTIR) spectroscopy 
(Spectrum100, Perkin Elmer) and X-ray diffraction (XRD) (Miniflex, 
Rigaku, Japan).
The macro- and microstructure of the ceramics were imaged on polished 
ceramic bodies with a scanning electron microscope (SEM; XL30, Philips) 
in the secondary electron mode. The grain sizes of the ceramics were 
determined by measuring the lateral distance of 60 different grains from 
three independent SEM images using Image J. The pore size distribution, 
microporosity (volume percentage of pores smaller than 10 µm) and 
specific surface area were determined using mercury intrusion porosimetry 
(Quantachrome Instruments, Pore Master). Density measurements were 
performed to determine the true (skeletal) density of the materials using 
a helium pyconometer (Accu Pyc II 1340 gas pyconometer, Micrometrics) 
and analyzed with Pore Master software.
Calcium ion release profiles were determined by incubating 
75 µL of ceramic granules in 1 mL of simulated physiological 
saline (SPS) (137 × 10−3 M Na+, 177 × 10−3 M Cl– and 50 × 10−3 M 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.3 at 
37 °C in demineralized water) with mild shaking (50 rpm) in a water 
bath and subsequently measuring calcium content using a calcium 
assay (QuantiChrom; BioAssay Systems).
Protein adsorption onto different materials was assessed by 
immersing 75 µL of ceramics in 1 mL of medium (containing 10% 
FBS, as described below) at 37 °C. After the indicated time points, the 
adsorbed proteins were lysed from the ceramics constructs with 150 µL 
RIPA (radio-immunoprecipitation assay) buffer with phosphatase and 
protease inhibitors. The ceramic particles were crushed and sonicated 
on ice, after which they were centrifuged for 10 min at 12 000 g at 4 °C. 
Total protein content of the supernatant was determined using a protein 
assay (BCA, Pierce).
5.3. In Vivo Characterization of Ectopic Bone Forming Capacity
Surgery was performed on six adult dogs (mongrel, male, 10–15 kg, 
1–2 years old) with the permission of the local animal care committee 
(Animal Centre, Sichuan University, Chengdu, China). All surgeries were 
conducted under general anesthesia by abdominal injection of sodium 
pentobarbital (30 mg kg−1 body weight). After shaving and sterilizing 
with iodine, a longitudinal skin incision and a median fascial incision 
were made, and the paraspinal muscles were exposed. Muscle pouches 
with length larger than 2 cm were made along the paraspinal muscle 
with blunt separation. Ceramic particles (1 mm) of HAn, HAi, BCPn, 
BCPi and TCP, or dense cylinders with cut gaps of TCPa and TCPb were 
loaded in individual muscle pouches. After the implants were sealed 
in the muscle pouches with silk sutures, the skin was suture closed. 
Following surgery, the animals were intramuscularly administered 
buprenorphine (0.1 mg per animal) for two days to relieve pain, and 
penicillin (40 mg kg−1) for three days to prevent infection. The animals 
were allowed full weight-bearing and received a normal diet. After 
12 weeks, the animals were sacrificed with an abdominal injection of 
sodium pentobarbital. Implants were harvested with surrounding tissue, 
trimmed, fixed in 4% formaldehyde, dehydrated with a gradient ethanol 
scale and embedded in PMMA. Non-decalcified sections were made 
using a diamond saw, stained with 1% methylene blue and 0.3% basic 
fuchsin solutions for light microscopy.
5.4. Replication of Surface Microtopography of  
Ceramics in Polystyrene
To replicate the topographical structure of ceramics in polystyrene 
substrates, two TCP ceramic discs were first imprinted in an 
intermediate mold of cyclic olefin copolymer (COC) (Tg = 140 °C, 
100 µm thickness). A hot embossing nanoimprint lithography 
machine (NIL 6”, Obducat, Malmö, Sweden) was used at 160 °C and 
50 bars pressure for 300 s, followed by cooling and demolding at 
60 °C. Thereafter, the intermediate mold was incubated in 1 M HCl 
for 1 h in order to remove the ceramic layer without influencing the 
topographical features. The COC intermediate molds were treated with 
oxygen plasma (50 sccm O2, 50 W, 75 mTOR, 30 s) prior to coating with 
fluoroctatrichlorosilane (FOTS). Finally, they were used to replicate the 
topographical features in polystyrene thin films (oriented PS, Polyflex 
clear grade, 75 µm thickness, Sidaplax). Again, hot embossing was 
used at 115 °C and 50 bar pressure for 300 s, followed by cooling and 
demolding at 60 °C. After imprinting, the polystyrene films replicating 
the topography of the ceramic discs were treated with oxygen plasma 
and sterilized in ethanol. Characterization of the replication was done by 
visual observation following SEM imaging.
5.5. Cell Culture
The human osteosarcoma cell line MG-63 was expanded in medium 
consisting of α-minimal essential medium supplemented 10% fetal 
bovine serum, 0.2 × 10−3 M ascorbic acid, 2 × 10−3 M l-glutamine, 
100 U mL−1 penicillin, and 100 µg mL−1 streptomycin. To investigate the 
effect of the ceramics, 200 000 cells in 100 µL of medium were seeded 
per 150 µL of particles pre-wetted with medium and allowed to attach 
for 4 h before adding additional medium. The cell-material constructs 
were cultured for 48 h or 7 days. As a reference, cells were seeded at low 
density (5 000 cells per cm2) and at high density (25 000 cells per cm2) 
on tissue culture polystyrene.
5.6. Transcriptional Profiling
5.6.1. RNA Isolation
After cell culture on the different materials, total RNA was isolated 
using the Nucleospin RNA isolation kit (Macherey–Nagel). Then, from 
275 ng of RNA, cRNA was synthesized using the Illumina TotalPrep RNA 
amplification kit, and both RNA and cRNA quality were verified on a 
Bioanalyzer 2100 (Agilent).
5.6.2. Gene Expression Profiling
Microarrays were performed using Illumina HT-12 v4 expression 
Beadchips. Briefly, 750 ng of cRNA was hybridized on the array overnight, 
after which the array was washed and blocked. Then, by addition of 
streptavidin Cy-3, a fluorescent signal was developed. Arrays were 
scanned on an Illumina Beadarray reader and raw intensity values were 
background corrected in BeadStudio (Illumina). Further data processing 
and statistical testing were performed using R and Bioconductor 
statistical software (reference). Graphical visualization of the data was 
obtained using GeneSpring software (Agilent Technologies and Strand Life 
Sciences). The probe-level raw intensity values were quantile normalized 
and transformed using variance stabilization (VSN). A linear modeling 
approach with empirical Bayesian methods, as implemented in Limma 
package,[57] was applied for differential expression analysis of the resulting 
probe-level expression values. P-values were corrected for multiple testing 
using the Benjamini and Hochberg method.[58] Genes were considered 
differentially expressed when a corrected p-value below 0.05 was reached.
5.6.3. Pathway and Network Analysis
Pathway over-representation analysis was performed using the webtool 
ConsensusPathDB (CPDB), which provides a comprehensive pathway 
analysis covering most public resources for interactions.[59] Over-
representation analysis was performed on a set of differentially expressed 
genes and a background list containing all measured genes was used to 
improve the statistical evaluation of the pathways. Pathways with a false 
discovery rate-corrected p-value <0.05 were considered significant.
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Network analysis was carried out in two steps. CPDB contains an 
induced network module which uses the interactions described in all the 
public resources to build a network based on a list of input genes. At 
first a network was generated on the same list of differentially expressed 
genes as used for pathway analysis using a z-score threshold of 18. Only 
binary protein interactions of low, medium, and high confidence were 
selected and intermediate genes were allowed to be added to the network 
in order to improve inter-gene connectivity. The resulting network was 
subsequently imported into CytoScape and the plugin CyTargetLinker 
was used to extend the CPDB network by adding transcription factors 
from the transcription factor target databases ENCODE (ENCyclopedia 
Of DNA Elements, proximal targets) and TFe (Transcription Factor 
encyclopedia).[60–63] ENCODE is based on a screening of ChIP-seq 
datasets while TFe is a smaller scale manual literature curation 
project containing 42 351 and 1531 human transcription factor target 
interactions respectively. The node degree distribution of the networks 
was analyzed using the built-in network analyzer option.
5.7. Validation of Datasets
The genes from the above experiment were independently validated in 
three other datasets. Firstly, a dataset published by Barradas et al.[32]  
was used. Specifically, donor-derived human mesenchymal stem 
cells (hMSC) were cultured on HAn and TCP (the same materials as 
in this study) in medium (same composition as described above) 
supplemented with 10 nM dexamethasone for various time points 
including 48 h. The second and third dataset used for validation of 
the identified genes included the same HAn and TCP ceramic particles 
on which an immortalized donor derived human mesenchymal stem 
cell line (iMSC) and MG-63 were cultured (in medium with the same 
composition) for 48 h.[41]
5.8. Quantitative Polymerase Chain Reaction
In order to investigate the regulation of gene expression, cDNA was 
prepared from RNA according to the manufacturer’s instructions 
(BioRad, USA). Quantitative RT-PCR was performed in a 20 µL 
volume with 0.01 nmol of forward and reverse primers. Thermocycling 
was performed at 60 °C for 15 s and 72 °C for 15 s for 35 cycles. 
β-2-Microglobulin (β2M) was used as a housekeeping gene and relative 
expression was determined using the ΔΔCT method. Primer sequences 
are provided in Table S in the Supporting Information.
5.9. Hyaluronic Acid Quantification
For the quantification of hyaluronic acid, 100 000 MG-63 cells in 50 µL of 
medium were seeded per 75 µL of particles and cultured in phenol-free 
α-MEM with the same medium components as mentioned above.
5.9.1. ELISA
The hyaluronic acid content in the extracellular matrix and cells adhering 
to the materials was quantified using the Hyaluronan Quantikine ELISA 
kit (R&D systems). Cell lysates, obtained by incubation with Cell Lysis 
Buffer 2 (R&D Systems) were loaded onto the ELISA plate and processed 
following the manufacturer’s instructions.
5.9.2. Hyaluronic Acid Size Analysis by Agarose Gel Electrophoresis
Cells cultured on the ceramic particles were washed once with PBS 
and subsequently subjected to proteinase K digestion for 4 h at 60 °C, 
vortexing every 30 min. The ceramics were removed by centrifugation and 
the supernatant was precipitated in 4 volumes of pre-chilled ethanol and 
incubated overnight at –20 °C. The next day, the samples were pelleted by 
centrifugation at 14 000 × g for 10 min at RT. The pellet was washed using 
4 volumes of pre-chilled 75% ethanol while vortexing. After a second 
centrifugation step, the supernatant was removed and the pellet air-dried for 
20 min at RT. The dried pellet was resuspended in 100 µL of 100 × 10−3 M 
ammonium acetate. Proteinase K was inactivated by incubating the 
samples at 100 °C for 5 min and then chilled on ice. Thereafter, nucleic 
acids were digested by incubation overnight with DNAse and RNAse A 
at 37 °C. The enzymes were inactivated in a boiling water bath for 5 min 
after which 400 µL of ethanol were added and incubated overnight at 
–20 °C. The samples were pelleted as before and washed with 1 mL of 
cold 75% ethanol. After centrifugation and removal of the supernatant, 
the pellets were air-dried and resuspended in 20 µL of ammonium acetate 
(100 × 10−3 M at pH 7). Half of each sample was digested with 1 µL of 
hyaluronidase (from Streptomyces hyalurolyticus, Sigma). The samples 
and a low-molecular-weight hyaluronic acid reference (15–30 kDa) were 
subsequently loaded on a 1% agarose gel and the resulting bands were 
visualized after staining with Stains-All (Sigma).
5.10. Statistics
Experiments carried out in duplicate or triplicate (as indicated in the 
figure legends) are defined respectively as two or three independent 
samples that were treated, isolated and analyzed separately. All 
experiments are presented as the mean ± standard deviation. Assays 
were analyzed using one or two way analysis of variance (ANOVA) 
with Bonferroni’s multiple comparison test, post-hoc Tukey test or 
Dunnett’s test, comparing the groups of interest. Statistics used during 
bioinformatics characterization are explained in detail in the respective 
subsection on gene expression profiling.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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